An interventional study of RAMP and Active control in Suicide Prevention, sponsored by VA Office of Research and Development. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies in Suicide Prevention by VA Office of Research and Development — 11 open to participants now, 12 under way, none of them phase 3. Suicide Prevention · VA Office of Research and Development.
Among the 20 studies in Suicide Prevention by VA Office of Research and Development, this one is the 17th largest by planned enrollment, is one of 3 that started in 2027, is one of 18 with no phase, reaches primary completion later than 9 of the 11 other live ones, and was the 15th registered.
187 studies on the registry are indexed under Suicide Prevention; 92 are open to participants now.
Browse Suicide Prevention studies →11 of the 20 studies in Suicide Prevention by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:
VA Office of Research and Development · Sites in United States
Ages 18+ · Healthy volunteers
VA Office of Research and Development · Sites in United States
Ages 18+
VA Office of Research and Development · Sites in United States
Ages 18+
VA Office of Research and Development · Sites in United States
Ages 18–65 · Healthy volunteers
VA Office of Research and Development · Sites in United States
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
Of the 53 Suicide Prevention studies recruiting now, 28 (53%) set no upper age limit and 21 (40%) stop at 75 or younger; 25 take children under 18; 21 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2
First in 2013; this study’s year is marked. 3 started in 2027.
This study's planned enrollment of 50 is below the median of 138 across 168 interventional studies indexed under Suicide Prevention.
Median enrollment 120 across the 20 interventional studies. Of the 7 that completed or were terminated, 6 (86%) have results posted.
This tab as a report to print or save as PDF → With an account.
VA Office of Research and Development is the lead sponsor of 1,774 studies on the registry; 394 are open to participants now.
Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.
4 of the studies in Suicide Prevention by VA Office of Research and Development that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06470867VA Office of Research and DevelopmentRandomized Controlled Effectiveness Trial of VA S.A.V.E. | 2026-11-27 |
| NCT05995678VA Office of Research and DevelopmentA Mixed Methods Pilot Trial of the STEP Home Workshop to Improve Reintegration and Reduce Suicide Risk for Recently Transitioned Veterans | 2027-05-31 |
| NCT05224440VA Office of Research and DevelopmentNational Sponsorship Program for Transitioning Service Members | 2027-09-30 |
| NCT07356492VA Office of Research and DevelopmentExpanding Veteran Sponsorship Initiative+ to Support High-Risk Transitioning Servicemembers and Veterans: A Precision Medicine Approach | 2027-09-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 20 studies in Suicide Prevention by VA Office of Research and Development, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Suicide prevention remains a significant priority and nearly three-quarters of Veteran suicides result from firearm injury. Since access to lethal means of self-harm increases the risk of injury, the VA/DoD Clinical Practice Guidelines recommend that Veterans with elevated suicide risk receive lethal means safety (LMS) counseling to reduce access to lethal means, including firearms. However, no LMS counseling interventions have been tested within VA. Thus, the aim of this study is to conduct a pilot randomized controlled trial to evaluate the feasibility and acceptability of a tailored LMS counseling intervention compared to an active control condition.
This is a pilot randomized controlled trial of up to 50 Veterans to assess the feasibility and acceptability of a LMS intervention and testing procedures.
The criteria were revised on the registry on Nov 9, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
For Veterans:
For clinicians (delivering intervention):
Exclusion Criteria:
For Veterans:
For clinicians (delivering intervention):
- Did not participate in training
The control condition will entail a 5-minute review of a pamphlet on suicide prevention with the Primary Care Mental Health Integration (PCMHI) clinician. This pamphlet is produced by the Veteran's Crisis Line and is widely available on the OSP suicide prevention website as a VHA resource. This condition will control for time and attention, subject matter, mode of delivery, and setting.
Behavioral: Active control
Participants randomized to the intervention condition will receive a brief, motivational interviewing-based intervention called RAMP (Raise the subject, Assess current storage, Motivate change, and Plan next steps) in the context of their clinical care. RAMP incorporates evidence-informed intervention components to facilitate secure firearm storage
Behavioral: RAMP
Participants randomized to the intervention condition will receive a brief, motivational interviewing-based intervention called RAMP (Raise the subject, Assess current storage, Motivate change, and Plan next steps) in the context of their clinical care. RAMP incorporates evidence-informed intervention components to facilitate secure firearm storage
The control condition will entail a 5-minute review of a pamphlet on suicide prevention with the Primary Care Mental Health Integration (PCMHI) clinician. This pamphlet is produced by the Veteran's Crisis Line and is widely available on the OSP suicide prevention website as a VHA resource. This condition will control for time and attention, subject matter, mode of delivery, and setting.
Screening
Investigators will assess the number of new Primary Care Mental Health Integration (PCMHI) patients seen in PCMHI and the number who were approached about potential study participation per month
Time frame: through study completion, approximately 2 years
Recruitment
Investigators will track the number of eligible Veterans who enrolled in the study per month
Time frame: through study completion, approximately 2 years
Retention
Investigators will calculate the number of Veterans who received RAMP who were willing to complete immediate and one-month follow up assessments.
Time frame: approximately 30 days
Assessment of behavioral outcomes
Investigators will assess the percentage of participants who completed behavioral outcome measures within the time allotted at each timepoint
Time frame: approximately 30 days
Veteran acceptability - Theoretical Framework of Acceptability
Investigators will assess Veteran acceptability using the eight Likert-style items from the Theoretical Framework of Acceptability questionnaire, which assess seven component constructs of acceptability including Veteran's experience of the lethal means safety intervention. Each item has 5 answer options (1-5) on a Likert Scale. Score range is 8 to 40, with a higher score indicating more higher reported acceptability.
Time frame: At immediate follow up, within approximately 2 weeks of intervention
Veteran acceptability - Experience and Satisfaction with intervention
Investigators will conduct qualitative evaluation of the participant's experience and satisfaction receiving the intervention.
Time frame: At immediate follow up, within approximately 2 weeks of intervention
Clinician acceptability - Theoretical Framework of Acceptability
Investigators will invite clinicians to respond to the eight-item Theoretical Framework of Acceptability questionnaire eliciting clinician acceptability of the lethal means safety intervention. Each item has 5 answer options (1-5) on a Likert Scale. Score range is 8 to 40, with a higher score indicating more higher reported acceptability.
Time frame: at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
Clinician acceptability - Negative impact
Investigators will assess to what extent Primary Care Mental Health Integration (PCMHI) clinicians agree that study recruitment negatively impacted clinical care, using Likert-type items where '1' indicates "strongly disagree" and '5' indicates "strongly agree." For those responding \>3 ("don't know"), an open-ended question will elicit detailed information (e.g., interfered with delivery of clinical care, led to Veteran frustration).
Time frame: at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jul 2027; primary completion for Jul 2029, 24 months later.
Of 129 non-industry interventional studies with no phase under Suicide Prevention, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 54. This study's planned 24 months is below that.
Counting every sponsor, half of 131 studies reached it within 28 months; a quarter within 12 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
VA Office of Research and Development →